BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Massachusetts Federal Court Again Dismisses Whistleblower Lawsuit Against Millennium Laboratories


1/30/2014 6:55:07 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Massachusetts Federal Court Again Dismisses Whistleblower Lawsuit Against Millennium Laboratories

SAN DIEGO
, Jan. 30, 2014 /PRNewswire/ -- U.S. District Judge Rya Zobel ordered the complete dismissal of a whistleblower suit brought by a former Calloway Laboratories' senior officer against Millennium Laboratories, a leader in the science of medication monitoring and pharmacogenetic testing. Although the Department of Justice had repeatedly asserted that it would not intervene in the lawsuit, and consented to the suit's initial dismissal in 2012, the civil suit continued for nearly two years. By entering final judgment in Millennium's favor and foreclosing any further amendment, the court closes a case that has been funded and used by Millennium's competitors in efforts to gain advantage in the marketplace.

(Logo: http://photos.prnewswire.com/prnh/20120224/MM59482LOGO)

After five years of litigation, Judge Zobel, in dismissing the whistleblower complaint, wrote that it set forth "no facts describing the circumstances of any unnecessary testing, or the dates when such occurred, or the amounts and dates of any improper claims" and "no allegations of an agreement between defendant and any physician to defraud the government."

Millennium has led a series of initiatives to address industry-wide ethical practices, including providing an unrestricted grant to Dr. Richard Payne of Duke University for the purpose of convening drug testing laboratories and other stakeholders to establish voluntary ethical business practices that meet or exceed federal and state regulations. The outcome of that effort will be announced in February. Millennium has also engaged prominent fraud, abuse, and compliance experts, including Lewis Morris, chief counsel to the HHS Office of Inspector General from 2002-2012, and Dick Kusserow of Strategic Management Systems, a former HHS Inspector General, to examine the company's comprehensive compliance program and evaluate its adherence to OIG's Compliance Program Guidance for Clinical Laboratories. Millennium's Compliance Policy is available at www.millenniumlabs.com.

About Millennium Laboratories

Millennium Laboratories, a leader in the science of medication monitoring and pharmacogenetic testing, is transforming the way health care professionals monitor and manage their patients' medication therapy. Through the use of advanced technology, supported by research and education, Millennium helps practitioners personalize care for patients. More information can be found at www.millenniumlabs.com.

SOURCE Millennium Laboratories, Inc.



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES